• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Bye-Bye China?

    Decentralized Trials Fuel AI Revolution in Clinical Research

    Self-Medication: Flexibility for Patients and Drug Manufacturers

    The Single-Use Mixing Landscape: Evaluating Your Options

    DCAT President Talks COVID-19, Drug Manufacturing and Innovation
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    KORSCH, MEDELPHARM Partner on R&D Equipment Portfolio

    Frontage Bolsters Clinical Services Capabilities

    Sanofi Unveils EUROAPI as Name of New European API Company

    Thermo Fisher Buys Novasep's Viral Vector Manufacturing Biz

    Precision Medicine Group Acquires Project Farma
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Sanofi Unveils EUROAPI as Name of New European API Company

    Precision Medicine Group Acquires Project Farma

    Cytiva Delivers Modular Biologics Factory to Lonza

    Fujifilm, CABIM Get $76M Funding for Mfg. and Innovation Center

    LSNE Expands Fill Finish and Lyophilization Ops
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Catalent Acquires Acorda’s INBRIJA Manufacturing Operations

    Varcode, PL Developments Form Strategic ‘Smart Tag’ Pact

    COVID-19 Vaccine Distribution: The Air Cargo Industry’s Greatest Challenge

    Thermo Fisher Expands Clinical Supply Services in Europe

    Schreiner MediPharm Joins DoseID Consortium
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Virtual Clinical Trials: The Future of Dermatology Studies

    Frontage Bolsters Clinical Services Capabilities

    Thermo Fisher Buys Novasep's Viral Vector Manufacturing Biz

    Precision Medicine Group Acquires Project Farma

    Cytiva Delivers Modular Biologics Factory to Lonza
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Gene Therapy Co. Selects ValGenesis' SaaS Platform

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

    Samsung Biologics Adopts Veeva Vault QMS to Unify Quality Management

    CDMO Cognate BioServices Teams Up with L7 Informatics

    The Wasdell Group Earns ISO 13485 Certification
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Emergent BioSolutions

    Alcami

    PCI Pharma Services

    Reed-Lane

    Cytovance Biologics
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Flow Sciences

    Cytovance Biologics

    Aphena Pharma Solutions

    Baxter BioPharma Solutions

    Alcami
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    CMAB Biopharma, BJ Bioscience in Strategic Development and Mfg. Pact

    CMAB will provide a full range of CMC research and manufacturing services to support IND applications for China and the U.S.

    CMAB Biopharma, BJ Bioscience in Strategic Development and Mfg. Pact
    Signing Ceremony of Strategic Collaboration Between BJ Bioscience and CMAB
    Related CONTENT
    • Vetio Animal Health
    • Emergent BioSolutions
    • Lonza Pharma & Biotech
    • CMAB Receives Positive Opinion Following External Quality Audit
    • Ajinomoto Bio-Pharma Services gives you The Power To Make
    10.11.19
    CMAB Biopharma (Suzhou) Inc., a biologics CDMO, and BJ Bioscience, an innovative biopharmaceutical company, have entered a strategic agreement for the development and manufacturing of a Bi-functional Antibody (BJ-005) as the first step in an exclusive collaboration.
     
    CMAB will provide a full range of CMC research and manufacturing services to support the IND application requirements of both China and the U.S. The collaboration will support the clinical development of BJ-005 worldwide by BJ Bioscience and will leverage CMAB's CMC process development and manufacturing platform, R&D team, and product quality system.

    "We had ambitious goals and aspirations at the beginning of setting up BJ Bioscience," said Mr. Xiaoyong, JIN, Chairman of BJ Bioscience. "So far, China's biopharmaceutical companies have very few innovative drugs on the market. We believe that BJ Bioscience will develop real innovative biologics in the foreseeable future. The primary goal for our cooperation with CMAB is that we may focus more on the innovative R&D fields that we are good at and leave the CMC part to CMAB because it is its expertise. We believe that our efforts in all respects will open up an era for stronger, win-win cooperation."
     
    "CMAB stood out in our strict screening of a number of CDMO companies for many reasons. We both think that talent prevails over everything. In recent years, BJ Bioscience has attracted many outstanding returnees and talents with both academic and biopharmaceutical industry experience. CMAB boasts a competent CMC research and manufacturing team covering the entire chain of CMC. CMAB, as a pure-play CDMO company, advocates absolute protection of the intellectual property rights of its customers. Therefore, we believe that our cooperation will accelerate the R&D process of BJ-005. We hope that such collaboration will speed up the development of the innovative therapies of BJ Bioscience to the patients worldwide," said Dr. Haizhou ZHANG, Co-founder and chief executive officer of BJ Bioscience.
     
    "We are extraordinarily delighted and honored to have the opportunity to provide CMC research and manufacturing services to cutting-edge biomedical R&D companies like BJ. CMAB fully understands the most critical needs of innovative drug R&D startups such as BJ. Our objective is to support BJ in attaining another milestone through the quality of IND applications in both China and the United States at the highest speed possible. CMAB will achieve this through our excellent core team, a mature technology integration capability, CDMO services, equipment and facilities of international mainstream brands, and a first-class international GMP quality system," said Dr. Yongzhong WANG, CMAB chief executive officer.
     
    Related Searches
    • patients
    • collaboration
    • it
    • Development
    Suggested For You
    Vetio Animal Health Vetio Animal Health
    Emergent BioSolutions Emergent BioSolutions
    Lonza Pharma & Biotech Lonza Pharma & Biotech
    CMAB Receives Positive Opinion Following External Quality Audit CMAB Receives Positive Opinion Following External Quality Audit
    Ajinomoto Bio-Pharma Services gives you The Power To Make Ajinomoto Bio-Pharma Services gives you The Power To Make
    CMAB and Kintor Enter Mfg. Tie-up CMAB and Kintor Enter Mfg. Tie-up
    Mereo BioPharma Appoints Head of Pharma Development Mereo BioPharma Appoints Head of Pharma Development
    Outsourcing in China: How far can it go? Outsourcing in China: How far can it go?
    The ADC Market is Fast Evolving The ADC Market is Fast Evolving
    Nitrosamines Nitrosamines
    SCHOTT Invests $1B in Pharmaceutical Packaging Biz SCHOTT Invests $1B in Pharmaceutical Packaging Biz
    WuXi Biologics, I-Mab Biopharma Ink Long-term Strategic Pact WuXi Biologics, I-Mab Biopharma Ink Long-term Strategic Pact
    Analytical CMC Outsourcing Analytical CMC Outsourcing

    Related Breaking News

    • Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
      EVOQ Therapeutics and Amgen Partner

      EVOQ Therapeutics and Amgen Partner

      Collaborate on the discovery and development of novel drugs for autoimmune disorders.
      Contract Pharma Staff 01.13.21

    • Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development
      Adagene Achieves CAR-T Collaboration Milestone

      Adagene Achieves CAR-T Collaboration Milestone

      Yields potential first-ever antibodies targeting human endogenous retrovirus associated with kidney cancer.
      Contract Pharma Staff 01.12.21

    • Bio News | Breaking News | Collaborations & Alliances | Drug Development | Industry News
      Cyclolab and EpiPharma Form Joint Venture

      Cyclolab and EpiPharma Form Joint Venture

      Will develop and commercialize Peptide drug candidates for the treatment of debilitating CNS and Pulmonary diseases.
      Contract Pharma Staff 01.11.21


    • Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News | Laboratory Testing
      Biohaven Acquires Remaining Stake in Kleo Pharmaceuticals

      Biohaven Acquires Remaining Stake in Kleo Pharmaceuticals

      Enters exclusive license agreement with Yale University for a novel extracellular degrader technology licensed from Spiegel Lab.
      Contract Pharma Staff 01.08.21

    • Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
      BrickBio Inks ADC Co-Development Deal

      BrickBio Inks ADC Co-Development Deal

      To co-develop a therapeutic antibody drug conjugate (ADC) with a large pharmaceutical company.
      Contract Pharma Staff 01.06.21

    • Analytical Services | Breaking News | cGMP Manufacture | Chemistry | Industry News
      Aceto to Acquire IsleChem

      Aceto to Acquire IsleChem

      Establishes chemical manufacturing and R&D capabilities in the U.S.
      Contract Pharma Staff 01.04.21


    • Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News | Information Technology
      Lantern Pharma Launches ADC Program

      Lantern Pharma Launches ADC Program

      Will leverage RADR artificial intelligence platform to target solid tumors and blood cancers through agreement with Califia Pharma.
      Contract Pharma Staff 01.04.21

    • Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Chemistry | Drug Development | Industry News
      Oncorus to Build GMP Viral Immunotherapy Mfg. Facility

      Oncorus to Build GMP Viral Immunotherapy Mfg. Facility

      88,000 sq.-ft. facility in Andover, MA will support multi-product pipeline of intratumorally and intravenously administered viral immunotherapies.
      Contract Pharma Staff 01.04.21

    • Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery
      Evotec, BMS Advance Targeted Protein Degradation Projects

      Evotec, BMS Advance Targeted Protein Degradation Projects

      The first two targets transition into drug discovery after completing a comprehensive target validation process.
      Contract Pharma Staff 12.17.20


    • Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
      INOVIO to Develop dMAb COVID Treatments under DARPA Grant

      INOVIO to Develop dMAb COVID Treatments under DARPA Grant

      $37.6 million grant will leverage AstraZeneca's monoclonal antibody and INOVIO's dMAb technologies in the fight against COVID-19.
      Contract Pharma Staff 12.15.20

    • Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
      Lilly to Acquire Prevail Therapeutics in $1B Deal

      Lilly to Acquire Prevail Therapeutics in $1B Deal

      Adds a new drug discovery and development modality and creates a gene therapy program anchored by Prevail's portfolio of neuroscience assets.
      Contract Pharma Staff 12.15.20

    • Breaking News | Clinical Trials | CRO News | Drug Development
      Ergomed Acquires MedSource

      Ergomed Acquires MedSource

      Specialist oncology and rare disease CRO further expands Ergomed’s presence in the U.S. market.
      Contract Pharma Staff 12.15.20


    • Breaking News | cGMP Manufacture | Drug Development | Industry News | R&D
      Ascentage Selects PharmaBlock as Preferred Provider

      Ascentage Selects PharmaBlock as Preferred Provider

      PharmaBlock will support Ascentage in accelerating its drug development pipeline with R&D, manufacturing capacity, and technological solutions.
      Contract Pharma Staff 12.11.20

    • Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
      Orgenesis, Cure Therapeutics Form JV

      Orgenesis, Cure Therapeutics Form JV

      Aims to advance point-of-care development and commercialization of cell and gene therapies.
      Contract Pharma Staff 12.10.20

    • Breaking News | Drug Development | Promotions & Moves
      Catalent Appoints Minakuchi Facility GM

      Catalent Appoints Minakuchi Facility GM

      Nakaya “Nick” Matsumaru joins the company from SymBio Pharmaceuticals.
      Contract Pharma Staff 12.10.20

    Trending
    • Fujifilm To Invest $2B In US Manufacturing Site
    • Baxter, Novavax Ink Sterile Manufacturing Agreement
    • A New Era Of Vaccine And Biologic Drug Development
    • Thermo Fisher Buys Novasep's Viral Vector Manufacturing Biz
    • Roche Canada To Invest $500M To Create 500 Jobs In Ontario
    Breaking News
    • KORSCH, MEDELPHARM Partner on R&D Equipment Portfolio
    • Frontage Bolsters Clinical Services Capabilities
    • Sanofi Unveils EUROAPI as Name of New European API Company
    • Thermo Fisher Buys Novasep's Viral Vector Manufacturing Biz
    • Precision Medicine Group Acquires Project Farma
    View Breaking News >
    CURRENT ISSUE

    November/December 2020

    • Modeling Process Safety Workflows in Pharmaceutical Manufacturing Scale-Up
    • Ensuring Quality During the Transfer and Scale Up of Rx Drugs
    • Inspecting the Unexpected
    • Cold Chain Trends
    • Catering for the Complex
    • Biopharma Contract Manufacturing: Robust Growth Ahead
    • DCAT President Talks COVID-19, Drug Manufacturing and Innovation
    • The Single-Use Mixing Landscape: Evaluating Your Options
    • Self-Medication: Flexibility for Patients and Drug Manufacturers
    • Decentralized Trials Fuel AI Revolution in Clinical Research
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Brown Fat Associated with Reductions in Chronic Disease Risk
    NIH Study Identifies Antibacterial Properties in Taurine
    NSF Begins New Certification Program
    Coatings World

    Latest Breaking News From Coatings World

    Zeppelin Acquires MTI Mischtechnik
    Ezio Braggio Joins ChemQuest Europe
    IFS Coatings Announce Carbon Offset Program
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Optimize EP Launches CaRM Cardiac Device Data Management Platform
    U.S. TAVR Market Projected to Reach Nearly $5 Billion by 2030
    FDA Clears Canon Medical's Compressed SPEEDER for 3D Exams on 1.5T MR
    Contract Pharma

    Latest Breaking News From Contract Pharma

    KORSCH, MEDELPHARM Partner on R&D Equipment Portfolio
    Frontage Bolsters Clinical Services Capabilities
    Sanofi Unveils EUROAPI as Name of New European API Company
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Neenah to Host Packaging Webinar for Printers
    W.S. Badger is Named a ‘150 Top Impact Company’
    Mana Products, Meiyume and RPG Form The Vertical Beauty Alliance
    Happi

    Latest Breaking News From Happi

    A Surge in Interest for Supplements & Vitamins
    P&G, L'Oréal & Amorepacific Make News at CES
    Three Form Vertical Beauty Alliance
    Ink World

    Latest Breaking News From Ink World

    dar-tech, inc. Becomes U.S. Midwestern Distributor for ZS Interpolymer
    Techkon USA, Konica Minolta Partner
    Alon Bar-Shany Appointed Chairman of Highcon Board
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Exhibitor registration opens for virtual.drupa
    FTA planning in-person Forum & INFOFLEX
    Fortis Solutions Group achieves SGP certification
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Shemesh Adds U.S. Headquarters
    TZMO USA, Special Needs Group Form Partnership
    BAHP Announces 2021 Officers, Board of Directors
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Rapid Recovery Protocol Can Lead to Increased Range of Motion After TKA
    Boston Scientific Releases WaveWriter Alpha Spinal Cord Stimulators in U.S.
    New Chief Clinical Officer on Board at IncludeHealth
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Roadsimple Modernizes Warehouse Ops with Zebra Technologies
    Toppan Announces 2050 Environmental Vision
    SOI Industry Consortium Joins SEMI as Strategic Association Partner

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login